Your browser doesn't support javascript.
Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
Lundberg, Lisa; Bygdell, Maria; Stukat von Feilitzen, Gustaf; Woxenius, Susanne; Ohlsson, Claes; Kindblom, Jenny M; Leach, Susannah.
  • Lundberg L; Dept. of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Bygdell M; Centre for Bone and Arthritis Research, Dept. of Internal Medicine and Clinical Nutrition, Inst. of Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Stukat von Feilitzen G; Dept. of Medical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Woxenius S; Dept. of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Ohlsson C; Centre for Bone and Arthritis Research, Dept. of Internal Medicine and Clinical Nutrition, Inst. of Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Kindblom JM; Centre for Bone and Arthritis Research, Dept. of Internal Medicine and Clinical Nutrition, Inst. of Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Pediatric Clinical Research Center, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Leach S; Dept. of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden; University of Gothenburg Vaccine Research Institute (GUVAX), Dept. of Microbiology and Immunology, Inst. of Biomedicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Electronic address: s
Vaccine ; 39(32): 4414-4418, 2021 07 22.
Article in English | MEDLINE | ID: covidwho-1275755
ABSTRACT

BACKGROUND:

It has been hypothesised that the measles-mumps-rubella (MMR) vaccine may afford cross-protection against SARS-CoV-2 which may contribute to the wide variability in disease severity of Covid-19.

METHODS:

We employed a test negative case-control study, utilising a recent measles outbreak during which many healthcare workers received the MMR vaccine, to investigate the potential protective effect of MMR against SARS-CoV-2 in 5905 subjects (n = 805 males, n = 5100 females).

RESULTS:

The odds ratio for testing positive for SARS-CoV-2, in recently MMR-vaccinated compared to not recently MMR-vaccinated individuals was 0.91 (95% CI 0.76, 1.09). An interaction analysis showed a significant interaction for sex. After sex-stratification, the odds ratio for testing positive for males was 0.43 (95% CI 0.24, 0.79, P = 0.006), and 1.01 (95% CI 0.83, 1.22, P = 0.92) for females.

CONCLUSION:

Our results indicate that there may be a protective effect of the MMR vaccine against SARS-CoV-2 in males but not females.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rubella / COVID-19 / Measles / Mumps Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: Vaccine Year: 2021 Document Type: Article Affiliation country: J.vaccine.2021.06.045

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Rubella / COVID-19 / Measles / Mumps Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: Vaccine Year: 2021 Document Type: Article Affiliation country: J.vaccine.2021.06.045